UNSPSC 85523005: Revision of autologous tissue substitute in upper vein, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in upper vein, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05WY47Z

UNSPSC 85523005 Revision of autologous tissue substitute in upper vein, percutaneous endoscopic approach is a Commodity code that shows little relevant recent activity under its nominal medical procedure classification. The recent opportunities posted under this code do not match its scope — they cover occupational medical surveillance, disability medical evaluations, pharmacy benefit management, surgical center-of-excellence networks, emergency youth detention healthcare, and temporary health professional staffing, none of which align with the percutaneous endoscopic revision of autologous vein grafts the code purports to describe. This appears to be a data-tagging or taxonomy-assignment misalignment in the state and local procurement systems rather than active procurement demand under the code itself.

The issuing bodies in the recent records span state departments, county health systems, county commissioners' offices, transit authorities, and municipalities across multiple states: the Washington State Department of Transportation (occupational medical services), Collier County Board of County Commissioners (pharmacy benefit management), Harris County Juvenile Probation Department (youth detention healthcare), the County of Santa Clara Health System (temporary staffing), the City of Long Beach (surgical benefits), and the City of Phoenix Retirement Office (disability medical evaluations). Geographic spread includes Washington, Florida, California, Arizona, and Texas. No current opportunities are actually soliciting autologous vascular tissue substitutes, revision procedures, or endoscopic approaches under this code. Business development professionals should treat this code as inactive for procurement purposes pending a taxonomy correction or retagging of opportunities to a code that matches the actual scope of work.